Literature DB >> 20352158

Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion.

Mariann Gyöngyösi1, Aniko Posa, Noemi Pavo, Rayyan Hemetsberger, Heda Kvakan, Sabine Steiner-Böker, Zsolt Petrási, Ferenc Manczur, Imre J Pavo, István F Edes, Johann Wojta, Dietmar Glogar, Kurt Huber.   

Abstract

Effects of ischaemic preconditioning (IP) on the mobilisation and recruitment of haematopoietic (HSCs) and mesenchymal stem (MSC) cells were determined in porcine coronary occlusion/reperfusion. Thirty-three pigs underwent percutaneous occlusion of the left anterior descending coronary artery (LAD) for 90 minutes (min), followed by 120 min reperfusion. IP was performed in 16 of the 33 pigs by two cycles of 5 min balloon occlusion/reperfusion prior to the 90 min occlusion (group IP vs. group C). Peripheral blood and myocardial tissue concentration of bone marrow origin HSCs (characterised by coexpression of CD31+, CD90+, CD45+) and MSCs (characterised by coexpression of CD44+, CD90+, CD45-) were measured by flow cytometry in the early phase of IP. Plasma/serum levels of stem cell mobilisation factors (stromal cell-derived factor-1a [SDF-1a], vascular endothelial growth factor [VEGF], tumour necrosis factor a[TNF-a] and interleukin-8 [IL-8]) were measured. IP led to a significant increase in circulating HSCs as compared with the group C (475 +/- 233 vs. 281 +/- 264 /ml, p=0.032) in the early phase of IP. In contrast, a rapid and prolonged decrease in level of circulating MSCs was observed in group IP as compared with group C (19 +/- 12 vs. 32 +/- 17 /ml, p=0.015). The recruitment of HSCs and MSCs in infarct and border zone was significantly greater in IP group, indicating a faster homing of MSCs as compared with the rate of mobilisation. Rapid increase in VEGF, TNF-a and IL-8 levels was induced by IP, which, however, was not correlated with the levels of circulating SCs. In conclusion, IP resulted in differential mobilisation and recruitment of HSCs and MSCs in the early phase of cardioprotection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352158     DOI: 10.1160/TH09-08-0558

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

Review 1.  Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?

Authors:  Martha L Arango-Rodriguez; Fernando Ezquer; Marcelo Ezquer; Paulette Conget
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

2.  Application of Chinese herbal medicines to revitalize adult stem cells for tissue regeneration.

Authors:  Hing-Lok Wong; Wing-sum Siu; Wai-ting Shum; Si Gao; Ping-Chung Leung; Chun-Hay Ko
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

Review 3.  Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.

Authors:  T Jadczyk; A Faulkner; P Madeddu
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

4.  Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model.

Authors:  Shiang Y Lim; Sarah T Hsiao; Zerina Lokmic; Priyadharshini Sivakumaran; Gregory J Dusting; Rodney J Dilley
Journal:  Tissue Eng Part A       Date:  2012-07-11       Impact factor: 3.845

5.  Experimental model for coadjuvant treatment with mesenchymal stem cells for aortic aneurysm.

Authors:  Luis Riera Del Moral; Carlota Largo Aramburu; José Ramón Ramírez García; Luis Riera de Cubas; Damián García-Olmo; Mariano García-Arranz
Journal:  Am J Stem Cells       Date:  2012-11-30

Review 6.  Preconditioning strategy in stem cell transplantation therapy.

Authors:  Shan Ping Yu; Zheng Wei; Ling Wei
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

7.  Remote ischemic conditioning: from bench to bedside.

Authors:  Shiang Yong Lim; Derek John Hausenloy
Journal:  Front Physiol       Date:  2012-02-20       Impact factor: 4.566

8.  Influence of BMI on level of circulating progenitor cells.

Authors:  Charles F Bellows; Yan Zhang; Paul J Simmons; Amrit S Khalsa; Mikhail G Kolonin
Journal:  Obesity (Silver Spring)       Date:  2011-02-03       Impact factor: 5.002

9.  Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.

Authors:  Michael Lichtenauer; Michael Mildner; Konrad Hoetzenecker; Matthias Zimmermann; Bruno Karl Podesser; Wolfgang Sipos; Ervin Berényi; Martin Dworschak; Erwin Tschachler; Mariann Gyöngyösi; Hendrik Jan Ankersmit
Journal:  Basic Res Cardiol       Date:  2011-09-28       Impact factor: 17.165

10.  Bioengineering silicon quantum dot theranostics using a network analysis of metabolomic and proteomic data in cardiac ischemia.

Authors:  Folarin Erogbogbo; Jasmine May; Mark Swihart; Paras N Prasad; Katie Smart; Seif El Jack; Dariusz Korcyk; Mark Webster; Ralph Stewart; Irene Zeng; Mia Jullig; Katherine Bakeev; Michelle Jamieson; Nikolas Kasabov; Banu Gopalan; Linda Liang; Raphael Hu; Stefan Schliebs; Silas Villas-Boas; Patrick Gladding
Journal:  Theranostics       Date:  2013-09-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.